(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Repare Therapeutics Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, April 2nd, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 29,622 | A-Award | A | 4,100 | 0.00 USD | 0 USD |
| Wednesday, April 2nd, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 24,500 | A-Award | A | 24,500 | 1.07 USD | 26,215 USD |
| Monday, March 31st, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 25,522 | 0 | 0.00 USD | 0 USD | ||
| Monday, March 31st, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 0 | 21,565 | 36.91 USD | 795,964 USD | ||
| Monday, March 31st, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 0 | 38,645 | 15.63 USD | 604,021 USD | ||
| Monday, March 31st, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 0 | 18,600 | 12.42 USD | 231,012 USD | ||
| Monday, March 31st, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 0 | 14,300 | 6.95 USD | 99,385 USD | ||
| Monday, March 31st, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 0 | 26,000 | 1.17 USD | 30,420 USD | ||
| Monday, March 31st, 2025 | Alves Sandra Isabelle Barros | officer: SVP, Finance and CAO | 0 | 57,736 | 6.79 USD | 392,027 USD | ||
| Wednesday, April 2nd, 2025 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 500,000 | A-Award | A | 500,000 | 1.07 USD | 535,000 USD |
| Wednesday, March 12th, 2025 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 227,813 | S-Sale | D | 3,596 | 1.14 USD | 4,099 USD |
| Wednesday, March 12th, 2025 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 80,297 | S-Sale | D | 5,611 | 1.14 USD | 6,397 USD |
| Wednesday, March 12th, 2025 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 54,786 | S-Sale | D | 6,884 | 1.14 USD | 7,848 USD |
| Wednesday, March 12th, 2025 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 124,394 | S-Sale | D | 21,179 | 1.14 USD | 24,144 USD |
| Tuesday, March 4th, 2025 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 237,000 | A-Award | A | 237,000 | 1.17 USD | 277,290 USD |
| Tuesday, March 4th, 2025 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 145,573 | A-Award | A | 40,000 | 0.00 USD | 0 USD |
| Tuesday, March 4th, 2025 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 85,908 | A-Award | A | 14,000 | 0.00 USD | 0 USD |
| Tuesday, March 4th, 2025 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 85,000 | A-Award | A | 85,000 | 1.17 USD | 99,450 USD |
| Tuesday, March 4th, 2025 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 75,000 | A-Award | A | 75,000 | 1.17 USD | 87,750 USD |
| Tuesday, March 4th, 2025 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 200,000 | A-Award | A | 200,000 | 1.17 USD | 234,000 USD |
| Tuesday, March 4th, 2025 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 85,000 | A-Award | A | 85,000 | 1.17 USD | 99,450 USD |
| Tuesday, March 4th, 2025 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 61,670 | A-Award | A | 14,000 | 0.00 USD | 0 USD |
| Monday, June 17th, 2024 | SCHAFER CAROL | director | 27,200 | A-Award | A | 27,200 | 3.80 USD | 103,360 USD |
| Monday, June 17th, 2024 | RHOADS ANN D | director | 27,200 | A-Award | A | 27,200 | 3.80 USD | 103,360 USD |
| Monday, June 17th, 2024 | Morrison Briggs | director | 27,200 | A-Award | A | 27,200 | 3.80 USD | 103,360 USD |
| Monday, June 17th, 2024 | Molineaux Susan | director | 27,200 | A-Award | A | 27,200 | 3.80 USD | 103,360 USD |
| Monday, June 17th, 2024 | Kulkarni Samarth | director | 27,200 | A-Award | A | 27,200 | 3.80 USD | 103,360 USD |
| Monday, June 17th, 2024 | Bonita David P | director | 27,200 | A-Award | A | 27,200 | 3.80 USD | 103,360 USD |
| Monday, June 17th, 2024 | Civik Thomas | director | 27,200 | A-Award | A | 27,200 | 3.80 USD | 103,360 USD |
| Monday, June 17th, 2024 | Stein Steven H | director | 54,000 | A-Award | A | 54,000 | 3.80 USD | 205,200 USD |
| Monday, June 17th, 2024 | Stein Steven H | 0 | 0 | 0.00 USD | 0 USD | |||
| Thursday, March 28th, 2024 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 110,049 | S-Sale | D | 2,650 | 4.62 USD | 12,243 USD |
| Monday, April 1st, 2024 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 107,558 | S-Sale | D | 2,491 | 4.63 USD | 11,533 USD |
| Thursday, March 28th, 2024 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 45,564 | S-Sale | D | 825 | 4.62 USD | 3,812 USD |
| Monday, April 1st, 2024 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 44,775 | S-Sale | D | 789 | 4.61 USD | 3,637 USD |
| Thursday, March 28th, 2024 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 72,318 | S-Sale | D | 450 | 4.64 USD | 2,088 USD |
| Monday, April 1st, 2024 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 71,908 | S-Sale | D | 410 | 4.66 USD | 1,911 USD |
| Thursday, March 28th, 2024 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 231,709 | S-Sale | D | 500 | 4.64 USD | 2,320 USD |
| Monday, April 1st, 2024 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 231,409 | S-Sale | D | 300 | 4.66 USD | 1,398 USD |
| Monday, March 25th, 2024 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 43,862 | S-Sale | D | 825 | 4.79 USD | 3,952 USD |
| Tuesday, March 26th, 2024 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 43,037 | S-Sale | D | 825 | 4.60 USD | 3,795 USD |
| Wednesday, March 27th, 2024 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 42,212 | S-Sale | D | 825 | 4.62 USD | 3,812 USD |
| Monday, March 25th, 2024 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 73,668 | S-Sale | D | 450 | 4.78 USD | 2,151 USD |
| Tuesday, March 26th, 2024 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 73,218 | S-Sale | D | 450 | 4.61 USD | 2,075 USD |
| Wednesday, March 27th, 2024 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 72,768 | S-Sale | D | 450 | 4.62 USD | 2,079 USD |
| Monday, March 25th, 2024 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 233,209 | S-Sale | D | 500 | 4.78 USD | 2,390 USD |
| Tuesday, March 26th, 2024 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 232,709 | S-Sale | D | 500 | 4.60 USD | 2,300 USD |
| Wednesday, March 27th, 2024 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 232,209 | S-Sale | D | 500 | 4.62 USD | 2,310 USD |
| Monday, March 25th, 2024 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 89,166 | S-Sale | D | 2,650 | 4.79 USD | 12,694 USD |
| Tuesday, March 26th, 2024 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 86,516 | S-Sale | D | 2,650 | 4.64 USD | 12,296 USD |
| Wednesday, March 27th, 2024 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 83,866 | S-Sale | D | 2,650 | 4.63 USD | 12,270 USD |
| Friday, March 1st, 2024 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 85,000 | A-Award | A | 85,000 | 6.95 USD | 590,750 USD |
| Friday, March 1st, 2024 | Forte Steve | officer: EVP, CHIEF FINANCIAL OFFICER | 44,687 | A-Award | A | 14,000 | 0.00 USD | 0 USD |
| Friday, March 1st, 2024 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 85,000 | A-Award | A | 85,000 | 6.95 USD | 590,750 USD |
| Friday, March 1st, 2024 | Zinda Michael | officer: EVP, CHIEF SCIENTIFIC OFFICER | 74,118 | A-Award | A | 14,000 | 0.00 USD | 0 USD |
| Friday, March 1st, 2024 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 237,000 | A-Award | A | 237,000 | 6.95 USD | 1,647,150 USD |
| Friday, March 1st, 2024 | Segal Lloyd Mitchell | director, officer: PRESIDENT AND CEO | 124,677 | A-Award | A | 40,000 | 0.00 USD | 0 USD |
| Friday, March 1st, 2024 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 233,709 | A-Award | A | 14,000 | 0.00 USD | 0 USD |
| Friday, March 1st, 2024 | Koehler Maria | officer: EVP, CHIEF MEDICAL OFFICER | 85,000 | A-Award | A | 85,000 | 6.95 USD | 590,750 USD |
| Monday, December 11th, 2023 | Koehler Maria | officer: EVP, Chief Medical Officer | 219,709 | M-Exempt | A | 23,556 | 2.43 USD | 57,123 USD |
| Monday, December 11th, 2023 | Koehler Maria | officer: EVP, Chief Medical Officer | 196,153 | M-Exempt | A | 20,190 | 2.06 USD | 41,632 USD |
| Monday, December 11th, 2023 | Koehler Maria | officer: EVP, Chief Medical Officer | 87,691 | M-Exempt | D | 23,556 | 2.43 USD | 57,123 USD |
| Monday, December 11th, 2023 | Koehler Maria | officer: EVP, Chief Medical Officer | 24,229 | M-Exempt | D | 20,190 | 2.06 USD | 41,632 USD |
| Thursday, November 16th, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 5,309,432 | P-Purchase | A | 153,693 | 5.38 USD | 827,437 USD |
| Wednesday, November 15th, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 5,155,739 | P-Purchase | A | 493,337 | 5.00 USD | 2,466,636 USD |
| Thursday, November 16th, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 4,308,573 | P-Purchase | A | 125,909 | 5.38 USD | 677,856 USD |
| Wednesday, November 15th, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 4,182,664 | P-Purchase | A | 390,507 | 5.00 USD | 1,952,496 USD |
| Thursday, November 16th, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 548,938 | P-Purchase | A | 16,143 | 5.38 USD | 86,909 USD |
| Wednesday, November 15th, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 532,795 | P-Purchase | A | 47,712 | 5.00 USD | 238,555 USD |
| Thursday, November 2nd, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 4,662,402 | P-Purchase | A | 218,979 | 3.60 USD | 788,324 USD |
| Thursday, November 2nd, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 3,792,157 | P-Purchase | A | 492,251 | 3.60 USD | 1,772,104 USD |
| Thursday, November 2nd, 2023 | BVF PARTNERS L P/IL | 10 percent owner | 485,083 | P-Purchase | A | 72,479 | 3.60 USD | 260,924 USD |
| Thursday, June 8th, 2023 | SCHAFER CAROL | director | 27,200 | A-Award | A | 27,200 | 11.66 USD | 317,152 USD |
| Thursday, June 8th, 2023 | RHOADS ANN D | director | 27,200 | A-Award | A | 27,200 | 11.66 USD | 317,152 USD |
| Thursday, June 8th, 2023 | Morrison Briggs | director | 27,200 | A-Award | A | 27,200 | 11.66 USD | 317,152 USD |
| Thursday, June 8th, 2023 | Molineaux Susan | director | 76,200 | A-Award | A | 76,200 | 11.66 USD | 888,492 USD |
| Thursday, June 8th, 2023 | Kulkarni Samarth | director | 27,200 | A-Award | A | 27,200 | 11.66 USD | 317,152 USD |
| Thursday, June 8th, 2023 | Foley Todd | director | 27,200 | A-Award | A | 27,200 | 11.66 USD | 317,152 USD |
| Thursday, June 8th, 2023 | Civik Thomas | director | 27,200 | A-Award | A | 27,200 | 11.66 USD | 317,152 USD |
| Thursday, June 8th, 2023 | Bonita David P | director | 27,200 | A-Award | A | 27,200 | 11.66 USD | 317,152 USD |
| Thursday, June 8th, 2023 | Molineaux Susan | director: | 0 | 0 | 0.00 USD | 0 USD | ||
| Wednesday, June 7th, 2023 | Zinda Michael | officer: EVP, Chief Scientific Officer | 62,987 | S-Sale | D | 6,404 | 12.03 USD | 77,040 USD |
| Thursday, June 8th, 2023 | Zinda Michael | officer: EVP, Chief Scientific Officer | 60,118 | S-Sale | A | 2,869 | 12.02 USD | 34,485 USD |
| Tuesday, June 6th, 2023 | Zinda Michael | officer: EVP, Chief Scientific Officer | 69,391 | S-Sale | D | 1,200 | 12.04 USD | 14,448 USD |
| Monday, January 30th, 2023 | Zinda Michael | officer: EVP, Chief Scientific Officer | 97,100 | A-Award | A | 97,100 | 12.42 USD | 1,205,982 USD |
| Monday, January 30th, 2023 | Zinda Michael | officer: EVP, Chief Scientific Officer | 70,591 | A-Award | A | 24,550 | 0.00 USD | 0 USD |
| Monday, January 30th, 2023 | Koehler Maria | officer: EVP, Chief Medical Officer | 175,963 | A-Award | A | 26,450 | 0.00 USD | 0 USD |
| Monday, January 30th, 2023 | Koehler Maria | officer: EVP, Chief Medical Officer | 119,250 | A-Award | A | 119,250 | 12.42 USD | 1,481,085 USD |
| Monday, January 30th, 2023 | Segal Lloyd Mitchell | director, officer: President and CEO | 344,200 | A-Award | A | 344,200 | 12.42 USD | 4,274,964 USD |
| Monday, January 30th, 2023 | Segal Lloyd Mitchell | director, officer: President and CEO | 84,677 | A-Award | A | 78,550 | 0.00 USD | 0 USD |
| Monday, January 30th, 2023 | Forte Steve | officer: EVP, Chief Financial Officer | 111,050 | A-Award | A | 111,050 | 12.42 USD | 1,379,241 USD |
| Monday, January 30th, 2023 | Forte Steve | officer: EVP, Chief Financial Officer | 30,687 | A-Award | A | 24,530 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 563,403 | J-Other | D | 287,157 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 65,957 | J-Other | A | 2,065 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 63,892 | J-Other | A | 1,866 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 62,026 | J-Other | A | 62,026 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 42,877 | J-Other | D | 21,854 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 25,131 | J-Other | A | 3,014 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 22,117 | J-Other | A | 1,240 | 0.00 USD | 0 USD |
| Thursday, December 29th, 2022 | Jerel Davis | director | 18,761 | J-Other | D | 9,561 | 0.00 USD | 0 USD |
